Remdesivir Drug Not Good For COVID-19 - WHO
The World Health Organisation in a stunning announcement Friday said Gilead’s drug remdesivir is no longer recommended for patients hospitalised with COVID-19, regardless of how ill they are.
According to a WHO panel, there is no evidence it improves survival or reduces the need for ventilation.
The Ebola drug was one of the drugs used to treat U.S. President Donald Trump’s coronavirus infection, and had been shown in previous studies to have cut time to recovery.
It is authorised or approved for use as a COVID-19 treatment in more than 50 countries.
But a WHO advisory said the drug is no more efficacious, following but a large WHO-led trial known as the Solidarity Trial.
The trial showed last month that it had little or no effect on 28-day mortality or length of hospital stays for COVID-19 patients.
“The … panel found a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement, and others,” the guideline said.
Please LOGIN or REGISTER To Gain Full Access To This Article
Wapbaze is an Entertainment website that deals in uploding of music tracks of any kind and letting her users download them in Mp3 formats of high quality. Wapbaze.com is the main website, Wapbaze.com/music/ is the folder for latest songs, wapbaze.com/movies/ is for mp4 movies updates so as wapbaze.com/videos/ is for 3gp music videos updates and wapbaze.com/forum/ is for latest gist, news, health and tech updates.